Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy

Annals of Neurology

Volumn 78, Issue 3, 2015, Pages 387-400

  Mariot, Virginie ^a,b,c,d   Roche, Stephane ^e   Hourdé, Christophe ^f   Portilho, Debora ^a,b,c,d   Sacconi, Sabrina ^g   Puppo, Francesca ^e   Duguez, Stephanie ^a,b,c,d   Rameau, Philippe ^h   Caruso, Nathalie ⁱ   Delezoide, Anne Lise ^b   Desnuelle, Claude ^g   Bessières, Bettina ^j   Collardeau, Sophie ^k   Feasson, Leonard ^l   Maisonobe, Thierry ^m   Magdinier, Frederique ^e   Helmbacher, Françoise ⁱ   Butler Browne, Gillian ^a,b,c,d   Mouly, Vincent ^a,b,c,d   Dumonceaux, Julie ^a,b,c,d  

^a Sorbonne Université   (France)

^b INSERM   (France)

^c CNRS   (France)

^d Institute of Myology   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f UNIVERSITÉ DE SAVOIE   (France)

^g UNIVERSITY HOSPITAL OF NICE   (France)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ AIX MARSEILLE UNIVERSITÉ   (France)

^j HÔPITAL NECKER ENFANTS MALADES   (France)

^k University Hospital Center   (France)

^l SERVICE DE NEUROLOGIE   (France)

^m PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DUX4; UNCLASSIFIED DRUG; CADHERIN; FAT1 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA METHYLATION; DOWN REGULATION; EMBRYO; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FAT1 GENE; FETUS; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUSE; MUSCLE BIOPSY; MYOTUBE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; EMBRYOLOGY; FEMALE; GENE EXPRESSION REGULATION; MALE; METABOLISM; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; PATHOLOGY; QUADRICEPS FEMORIS MUSCLE; SKELETAL MUSCLE;

ADULT; ANIMALS; CADHERINS; CELLS, CULTURED; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MALE; MICE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; QUADRICEPS MUSCLE;

EID: 84939654856     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24446     Document Type: Article

References (41)

1. Tawil R, van der Maarel SM, Tapscott SJ,. Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skelet Muscle 2014; 4: 12.
2. Deenen JC, Arnts H, van der Maarel SM, et al., Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology 2014; 83: 1056-1059.
3. Tawil R,. Facioscapulohumeral muscular dystrophy. Neurotherapeutics 2008; 5: 601-606.
4. Sacconi S, Salviati L, Desnuelle C,. Facioscapulohumeral muscular dystrophy. Biochim Biophys Acta 2014; 4: 607-614.
5. Padberg GW, Brouwer OF, de Keizer RJ, et al., On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve 1995; 2: S73-S80.
6. Brouwer OF, Padberg GW, Ruys CJ, et al., Hearing loss in facioscapulohumeral muscular dystrophy. Neurology 1991; 41: 1878-1881.
7. Lutz KL, Holte L, Kliethermes SA, et al., Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy. Neurology 2013; 81: 1374-1377.
8. Trevisan CP, Pastorello E, Tomelleri G, et al., Facioscapulohumeral muscular dystrophy: hearing loss and other atypical features of patients with large 4q35 deletions. Eur J Neurol 2008; 15: 1353-1358.
9. van Deutekom JC, Wijmenga C, van Tienhoven EA, et al., FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 1993; 2: 2037-2042.
10. Wijmenga C, Frants RR, Brouwer OF, et al., Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 1990; 336: 651-653.
11. Lemmers RJ, Tawil R, Petek LM, et al., Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 2012; 44: 1370-1374.
12. Lemmers RJ, de Kievit P, Sandkuijl L, et al., Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat Genet 2002; 32: 235-236.
13. Lemmers RJ, Wohlgemuth M, Frants RR, et al., Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy. Am J Hum Genet 2004; 75: 1124-1130.
14. Lemmers RJ, van der Vliet PJ, Klooster R, et al., A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 2010; 329: 1650-1653.
15. Thomas NS, Wiseman K, Spurlock G, et al., A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere. J Med Genet 2007; 44: 215-218.
16. Dixit M, Ansseau E, Tassin A, et al., DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A 2007; 104: 18157-18162.
17. Snider L, Asawachaicharn A, Tyler AE, et al., RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum Mol Genet 2009; 18: 2414-2430.
18. Vanderplanck C, Ansseau E, Charron S, et al., The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS One 2011; 6: e26820.
19. Tassin A, Laoudj-Chenivesse D, Vanderplanck C, et al., DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? J Cell Mol Med 2012; 17: 76-89.
20. Geng LN, Yao Z, Snider L, et al., DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell 2012; 22: 38-51.
21. Jones TI, Chen JC, Rahimov F, et al., Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum Mol Genet 2012; 21: 4419-4430.
22. Broucqsault N, Morere J, Gaillard MC, et al., Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy. Hum Mol Genet 2013; 22: 4206-4214.
23. Ferreboeuf M, Mariot V, Bessieres B, et al., DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles. Hum Mol Genet 2014; 23: 171-181.
24. Caruso N, Herberth B, Bartoli M, et al., Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy. PLoS Genet 2013; 9: e1003550.
25. Sopko R, McNeill H,. The skinny on Fat: an enormous cadherin that regulates cell adhesion, tissue growth, and planar cell polarity. Curr Opin Cell Biol 2009; 21: 717-723.
26. Tanoue T, Takeichi M,. Mammalian Fat1 cadherin regulates actin dynamics and cell-cell contact. J Cell Biol 2004; 165: 517-528.
27. Braun GS, Kretzler M, Heider T, et al., Differentially spliced isoforms of FAT1 are asymmetrically distributed within migrating cells. J Biol Chem 2007; 282: 22823-22833.
28. Gaillard MC, Roche S, Dion C, et al., Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers. Neurology 2014; 83: 733-742.
29. Bustin SA, Benes V, Garson JA, et al., The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009; 55: 611-622.
30. Nagae S, Tanoue T, Takeichi M,. Temporal and spatial expression profiles of the Fat3 protein, a giant cadherin molecule, during mouse development. Dev Dyn 2007; 236: 534-543.
31. Chen H,. Atlas of genetic diagnosis and counseling. Totowa, NJ: Humana Press, 2006.
32. Krom YD, Dumonceaux J, Mamchaoui K, et al., Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD. Am J Pathol 2012; 181: 1387-1401.
33. Snider L, Geng LN, Lemmers RJ, et al., Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet 2010; 6: e1001181.
34. Yao Z, Snider L, Balog J, et al., DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle. Hum Mol Genet 2014; 23: 5342-5352.
35. Young JM, Whiddon JL, Yao Z, et al., DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis. PLoS Genet 2014; 9: e1003947.
36. Puppo F, Dionnet E, Gaillard MC, et al., Identification of variants in the 4q35 gene FAT1 in patients with a facioscapulohumeral dystrophy-like phenotype. Hum Mutat. 2015; 36: 443-453.
37. Ciani L, Patel A, Allen ND, ffrench-Constant C,. Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Mol Cell Biol 2003; 23: 3575-3582.
38. Mahoney PA, Weber U, Onofrechuk P, et al., The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily. Cell 1991; 67: 853-868.
39. Scionti I, Fabbri G, Fiorillo C, et al., Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling. J Med Genet 2012; 49: 171-178.
40. Cabianca DS, Casa V, Bodega B, et al., A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell 2012; 149: 819-831.
41. Tanoue T, Takeichi M,. New insights into Fat cadherins. J Cell Sci 2005; 118: 2347-2353.